Selective estrogen receptor modulator
This page covers all Selective estrogen receptor modulator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Estrogen receptor.
Targets
Phase 3 pipeline (3)
- DR-103 · Teva Women's Health · Women's Health
DR-103 is a medication used to treat a specific condition by targeting a particular biological pathway. - Duration of Treatment: 3 months · Organon and Co · Gynecology
This drug works by inhibiting the activity of a specific enzyme. - Duration of Treatment: 6 weeks · Organon and Co · Gynecology
This drug works by inhibiting the activity of a specific enzyme.
Phase 2 pipeline (2)
- Graceptor® · Astellas Pharma Inc · Oncology
Selective estrogen receptor modulator - INEGY · Organon and Co · Women's Health
Selective estrogen receptor modulator